Related Experiment Videos
P57 (KIP2) polymorphisms and breast cancer risk
1Department of Epidemiology, School of Public Health and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill 27599-7400, USA.
Human Genetics
|March 10, 1999
Summary
Germline deletions in the P57 gene
Area of Science:
- Genetics
- Cancer Biology
- Molecular Epidemiology
Background:
- Previous research suggested a link between P57 (KIP2) proline-alanine-rich (PAPA-repeat) region deletions and various cancer risks.
- The P57 gene plays a role in cell cycle regulation and tumor suppression.
Purpose of the Study:
- To investigate the association between P57 PAPA-repeat deletion polymorphisms and breast cancer risk.
- To validate or refute previous findings on P57 deletions and cancer predisposition.
Main Methods:
- A population-based case-control study design was employed.
- Analysis focused on the presence of one or two copies of deletion polymorphisms in the P57 gene.
- Statistical methods included calculating adjusted odds ratios and confidence intervals.
Main Results:
- No significant association was observed between P57 PAPA-repeat deletion polymorphisms and breast cancer risk.
- The adjusted odds ratio for breast cancer risk was 1.1 (95% CI: 0.6-2.0).
Conclusions:
- The study did not find evidence supporting an association between P57 deletion polymorphisms and increased breast cancer risk.
- Further research is needed to clarify the functional significance of P57 deletion polymorphisms and their role in disease.